Log on / register
Feedback | Support | My details
Evaluating the cytotoxicity of innate immune effector cells using the GrB ELISPOT assay.
Shafer-Weaver KA, Sayers T, Kuhns DB, Strobl SL, Burkett MW, Baseler M, Malyguine A
J Transl Med 2004 Sep 20, 2:31
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

PubMed Central articles that cite the above article:

1.
Identification of a new HLA-A*0201-restricted CD8+ T cell epitope from hepatocellular carcinoma-associated antigen HCA587.
Li B, Wang Y, Chen J, Wu H, Chen W
Clin Exp Immunol 2005 May, 140:310-9
 [PubMed Central] [PubMed] [Related articles]
2.
Preclinical characterization of 1-7F9, a novel human anti-KIR receptor therapeutic antibody that augments natural killer-mediated killing of tumor cells.
Romagné F, André P, Spee P, Zahn S, Anfossi N, Gauthier L, Capanni M, Ruggeri L, Benson DM, Blaser BW, Della Chiesa M, Moretta A, Vivier E, Caligiuri MA, Velardi A, Wagtmann N
Blood 2009 Sep 24, 114:2667-77
 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 1 article in BioMed Central

printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.